Prescription Description
| Prescription ID | TCMFx4808 |
| Pinyin Name | Nao Xin Shu Kou Fu Ye |
| Chinese Name | 脑心舒口服液 |
| English Name | Nao Xin Shu Oral Liquid |
| Function Description | 不寐, 眩晕, 头痛 |
| Indications | Vertigo disorder, Insomnia disorder, Insomnia, Headache, Dizziness |
| Disease ICD-11 Category |
SD22 [Vertigo disorder (TM1), 眩晕 (TM1)
]; SD84 [Insomnia disorder (TM1), 不寐 (TM1) ]; 7A0Z [Insomnia disorders, unspecified, 失眠障碍，未特指的 ]; MB6Y [Other specified symptoms or signs involving the nervous system, 其他特指的累及神经系统的症状或体征 ]; MB48 [Dizziness and giddiness, 头晕和眩晕 ]; |
| Human Tissues Associated with Indication | Brain, Heart |
| Reference | CFDA |
| Reference Book/link | http://samr.cfda.gov.cn/WS01/CL0001/ |
Targeted Human Proteins by the Ingredients of Prescription
| Target ID | Gene Symbol | Target Name | Target Class | Uniprot ID |
|---|
Targeted Pathogenic Microbes by the Ingredients of Prescription
| Target ID | Target Name |
|---|
Gene Ontology Associated to Targeted Human Proteins
| GO Term | GO Name | Enriched Genes | Log10 Adjusted P-value |
|---|
KEGG Pathways Associated to Targeted Human Proteins
| KEGG Pathway ID | Enriched Genes | Log10 Adjusted P-value |
|---|
Target Exprsssion in Healthy Human Tissues (protein & mRNA level)
Protein expression data was from the "Human Proteome Map" datasetmRNA expression data was from the "GTEx" dataset
Average Target Expression (Fold Change) in Multiple Disease Conditions
Fold Change with Corresponding Normal SamplesClick each cell within the heatmap to access gene expression of individual patient samples